TABLE 2.
Variable* | Levels | OR/Coefficient | 95% CI | P-value |
IGLV5-37 | High expression level | 1.82 | (1.13; 2.93) | 0.014 |
IGHJ3 | High expression level | 1.63 | (1.01; 2.63) | 0.046 |
IGHV1OR15-1 | High expression level | 1.82 | (1.05; 3.15) | 0.033 |
PTF1A | High expression level | 1.73 | (1.06; 2.84) | 0.029 |
ARID3C | High expression level | 0.59 | (0.37; 0.96) | 0.032 |
FREM2 | High expression level | 0.61 | (0.38; 0.99) | 0.046 |
CLDN19 | High expression level | 1.65 | (1.02; 2.65) | 0.040 |
CROCC2 | High expression level | 1.65 | (1.02; 2.65) | 0.040 |
SPAG6 | High expression level | 1.73 | (1.07; 2.79) | 0.025 |
MAGEA9B | High expression level | 1.97 | (1.13; 3.41) | 0.016 |
ONECUT1 | High expression level | 1.71 | (1.01; 2.91) | 0.046 |
SOHLH1 | High expression level | 1.67 | (1.03; 2.69) | 0.036 |
Tumor residual disease | No macroscopic disease | Ref | – | – |
1–10 mm | 1.53 | (0.70; 3.34) | 0.285 | |
11–20 mm | 1.64 | (0.53; 5.10) | 0.396 | |
>20 mm | 3.14 | (1.31; 7.54) | 0.010 | |
Unknown | 1.29 | (0.47; 3.54) | 0.626 | |
Age | year | 0.01 | (0.00; 0.01) | <0.001 |
*Data are odds ratio and 95% confidence interval for category variables as well as coefficient (β) and 95% confidence interval for the numeric variable (Age).